Thrombotic microangiopathies associated with drugs and bone marrow transplantation

Hematology/Oncology Clinics of North America

Volumn 10, Issue 2, 1996, Pages 485-497

  Moake, J L ^a   Byrnes, J J ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; AZATHIOPRINE; CYCLOSPORIN A; DIPYRIDAMOLE; IMMUNOGLOBULIN; MITOMYCIN C; PREDNISONE; VON WILLEBRAND FACTOR;

BONE MARROW TRANSPLANTATION; CELL DAMAGE; CLINICAL TRIAL; ENDOTHELIUM CELL; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFARCTION; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIA; NEPHRITIS; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SPLENECTOMY; THROMBOCYTE AGGREGATION; THROMBOCYTE TRANSFUSION; THROMBOTIC THROMBOCYTOPENIC PURPURA; WHOLE BODY RADIATION;

EID: 0029942551     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70348-8     Document Type: Article

References (66)

1. C. Antignac M.-C. Gubler G. Leverger Delayed renal failure with extensive mesangiolysis following bone marrow transplant Kidney Int 35 1989 1336
2. K. Atkinson J.C. Biggs J. Hayes Cyclosporine A associated nephrotoxicity in the first 100 days after allogenic bone marrow transplantation: Three distinct syndromes Br J Haematol 54 1983 59
3. J. Bergstein S.P. Andreoli A.J. Provisor Radiation nephritis following total-body irradiation and cyclophosphamide in preparation for bone marrow transplantation Transplantation 41 1986 63
4. J.M. Bergstein U. Kuederli N.U. Bang Plasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndrome Am J Med 73 1982 322
5. Z. Brown G.H. Neild Cyclosporine inhibits prostacyclin production by cultured human endothelial cells Transplant Proc 19 1987 1178
6. Z. Brown G. Neild J.J. Willoughby Increased factor VIII as an index of vascular injury in cyclosporin nephrotoxicity Transplantation 42 1986 150
7. J.J. Byrnes H. Baquerizo M. Gonzalez Thrombotic thrombocytopenic purpura subsequent to acute myelogenous leukemia chemotherapy Am J Hematol 21 1986 299
8. J.J. Byrnes J.L. Moake Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome: Evolving concepts of pathogenesis and therapy Clin Haematol 15 1986 413
9. V. Cattell Mitomycin-induced hemolytic uremic kidney: An experimental model in the rat Am J Pathol 121 1985 88
10. M.E. Chappell D.M. Keeling H.G. Prentice Haemolytic uremic syndrome after bone marrow transplantation: An adverse effect of total body irradiation? Bone Marrow Transplant 3 1988 339
11. D. Charbra J.L. Moake M.A. Harris Abnormalities of von Willebrand factor multimers in drug-associated thrombotic microangiopathies Am J Hematol 42 1993 268
12. H. Cohen H.A. Bull A. Seddon Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogenic bone marrow transplantation Eur J Haematol 43 1989 207
13. P.W. Collins A. Gutteridge A. O'Driscoll von Willebrand factor as a marker of endothelial cell activation following BMT Bone Marrow Transplant 10 1992 499
14. J. Craig T. Sheehan K. Bell The haemolytic-uraemic syndrome and bone marrow transplantation Br Med J 295 1987 887
15. J.T. Crosson W.F. Keane W.R. Anderson Radiation Nephrology C.C. Tisher B.M. Brenner Renal Pathology vol 1 1989 JB Lippincott Philadelphia 866
16. K. DaSilva D. Pasquale M.F. Tsan Cyclosporine A (CyA), an effective therapy for thrombotic thrombocytopenic purpura Blood 82 1993 411a
17. P.S. Gable W.S. Smith F.E. Millard Cyclosporine in relapsed thrombotic thrombocytopenic purpura Blood 82 1993 604a
18. J.L. Gottschall W. Elliot E. Lianos Quinine-induced immune thrombocytopenia associated with hemolytic-uremic syndrome: A new clinical entity Blood 77 1991 306
19. J.L. Gottschall B. Neahring J.G. McFarland Quinine-induced immune thrombocytopenia with hemolytic uremic syndrome: Clinical and serological findings in nine patients and review of the literature Am J Hematol 47 1994 283
20. A.A. Grace M.A. Barradas D.P. Mikhailidis Cyclosporine A enhances platelet aggregation Kidney Int 32 1987 889
21. E.C. Guinan N.J. Tarbell C.M. Neimeyer Intravenous hemolysis and renal insufficiency after bone marrow transplantation Blood 72 1988 451
22. R. Habib Pathology of the hemolytic uremic syndrome B.S. Kaplan R.S. Trompeter J.L. Moake Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura 1992 Marcel Dekker New York 315
23. 2 and theophylline on the response of platelets subjected to shear stress Blood 58 1981 678
24. E. Holler H.J. Kolb E. Hiller Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation Blood 73 1989 2018
25. J.M. Hows J.M. Smoth A. Baughn Nephrotoxicity in marrow graft recipients treated with cyclosporine Transplant Proceedings 15 1983 2708
26. V. Hug A. Burgess Effect of cyclophosphamide on the mitomycin induced syndrome of thrombotic thrombocytopenic purpura Cancer Treat Rep 69 1985 565
27. T. Ichimashi T. Maoe H. Yoshida Hemolytic uremic syndrome during FK 506 therapy Lancet 33 1992 6061
28. S. Jain A.E. Seymour Mitomycin C associated hemolytic uremic syndrome Pathology 19 1987 58
29. P.R.E. Johnson I.A. Liu Lin M.T. Drayson Thrombotic thrombocytopenic purpura following allogenic bone marrow transplantation Bone Marrow Transplant 7 1991 321
30. M. Juckett E.H. Perry B.S. Daniels Hemolytic uremic syndrome following bone marrow transplantation Bone Marrow Transplant 5 1990 61
31. J.G. Kelton J. Moore A. Santos D. Sheridan Detection of a platelet aggregating factor in thrombotic thrombocytopenic purpura Ann Intern Med 101 1984 589
32. H. Kierdorf M. Maurin B. Heinz Cyclosporine for thrombotic thrombocytopenic purpura Ann Intern Med 118 1993 987
33. S. Korec P.S. Schein F.P. Smith Treatment of cancer-associated hemolytic-uremic syndrome with staphylococcal protein A immunoperfusion J Clin Oncol 4 1986 210
34. L.J. Loomis A.J. Aronson R. Rudinsky Hemolytic uremic syndrome following bone marrow transplantation: A case report and review of the literature Am J Kidney Dis 14 1989 324
35. A.J. Marcus L.B. Safier K.A. Hajjar Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells J Clin Invest 88 1991 1690
36. R.J. Marshall P. Sweny Haemolytic-uremic syndrome and bone marrow transplantation Br Med J 295 1987 887
37. R. Misiani A.C. Apiani A. Eedefonti Haemolytic-uraemic syndrome: Therapeutic effect of plasma infusion Br Med J 285 1982 1304
38. J.L. Moake Thrombotic thrombocytopenic purpura Thromb Haemost 74 1995 240
39. J.L. Moake J.J. Byrnes J.H. Troll Abnormal VIII: von Willebrand factor patterns in the plasma of patients with the hemolytic-uremic syndrome Blood 64 1984 592
40. J.L. Moake J.J. Byrnes J.H. Troll Effects of fresh frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura Blood 65 1985 1232
41. J. Moake M. Chintagumpala N. Turner Solvent/detergent-treated plasma contains the component that reverses von Willebrand factor-mediated shear-induced platelet aggregation and prevents episodes of chronic relapsing thrombotic thrombocytopenic purpura Blood 84 1994 490
42. J.L. Moake P.D. McPherson Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome Am J Med 87 1989 9N
43. J.L. Moake C.K. Rudy J.H. Troll Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura N Engl J Med 307 1982 1432
44. J.L. Moake N.A. Turner N.A. Stathopoulos Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation J Clin Invest 78 1986 1456
45. J.L. Moake N.A. Turner N.A. Stathopoulos Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as exogenous large or unusually large vWF multimers, requires adenosine diphosphate and is resistant to aspirin Blood 71 1988 1366
46. J. Monteagudo A. Pereira S. Roig Investigation of plasma von Willebrand factor and circulating platelet aggregating activity in mitomycin C-related hemolytic-uremic syndrome Am J Hematol 33 1990 46
47. M. Noris A. Benigni R. Seigler Renal prostacyclin biosynthesis is reduced in children with hemolytic-uremic syndrome in context of systemic platelet activation Am J Kidney Dis 20 1992 144
48. D.M. Peterson N.A. Stathopoulos T.D. Giorgio Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb/IIa Blood 69 1987 625
49. S.L. Pfueller R.A. Bilston S. Jane Expression of the drug-dependent antigen for quinine-dependent antiplatelet antibodies on GPIIIa, but not on GPIb, IIb or IX on human endothelial cells Thromb Haemost 63 1990 279
50. R.L. Powles H.M. Clink D. Spence Cyclosporine A to prevent graft vs host disease in man after allogenic bone marrow transplantation Lancet 1 1980 327
51. A.D. Proia E.A. Harden H.R. Silberman Mitomycin-induced hemolytic-uremic syndrome Arch Pathol Lab Med 108 1984 959
52. S.N. Rabinowe R.J. Soiffer N.J. Tarbell Hemolytic uremic syndrome following bone marrow transplantation in adults for hematological malignancies Blood 77 1991 1837 1844
53. R. Sarode J.G. McFarland N. Flomenerg Therapeutic plasma exchange not effective in the management of TTP/HUS following bone marrow transplantation Blood 82 1993 419a
54. R.J. Schmidt K.K. Venkat F. Dumler Hemolytic-uremic syndrome in a renal transplant recipient on FK506 immunosupression Transplant Proc 234 1991 3156
55. A.E. Schorer P.D. Rick W.R. Swam C.F. Moldow Structural features of endotoxin required for stimulation of endothelial cell tissue factor production; exposure of preformed tissue factor after oxidant-mediated endothelial cell injury J Lab Clin Med 106 1985 38
56. H. Schulman G. Striker J.H. Deeg Nephrotoxicity of cyclosporine A after allogenic marrow transplantation: Glomerular thrombosis and tubular injury N Engl J Med 305 1981 1392
57. K.J. Sheth J.C. Gill J. Hanna Failure of fresh frozen plasma infusions to alter the course of hemolytic-uremic syndrome Child Nephrology and Urology 9 1988 38
58. V.A. Silva D. Frei-Lahr R.A. Brown Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation J Clin Apheresis 6 1991 16
59. H.W. Snyder A. Mittleman E. Oral Treatment of cancer thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma Cancer 71 1993 1882
60. L.A. Sporn P. Rubin V.J. Marder Irradiation induces release of von Willebrand protein from endothelial cells in culture Blood 64 1984 567
61. W.E. Spruce S.J. Forman K.G. Blume Hemolytic uremic syndrome after bone marrow transplantation Acta Haematol 67 1982 206
62. B.T. Steele D.S. Lirenman Acute radiation nephritis and the hemolytic uremic syndrome Clin Nephrol 11 1979 272
63. D.F. Stroncek G.M. Vercellotti D.E. Hammerschmidt Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic-uremic syndrome and immune agranulocytosis Blood 80 1992 241
64. W.C. Symmers Thrombotic microangiopathic haemolytic anemia Br Med J 2 1952 897
65. N.J. Tarbell E.C. Guinan C. Niemeyer Late onset of renal dysfunction in survivors of bone marrow transplantation Int J Radiat Oncol Biol Phys 15 1988 99
66. M. Tschuchnig K.F. Bradstock J. Koutts A case of thrombotic thrombocytopenic purpura following allogenic bone marrow transplantation purpura Bone Marrow Transplant 7 1991 405